Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAUShell Companies
-$0.00 today
- Market cap
- $153.15M
- Beta
- 0.03
- P/E (TTM)
- 194.6
- EPS (TTM)
- $0.05
Volume 0.00M
Average 0.00M
HAVAU Other Financing Activities
Financing cash flows not reported separately.
Harvard Ave Acquisition Corporation UnitNASDAQ: HAVAU
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities declines year over year
Q1 FY2026 other financing activities of $8.49K (cash outflow) fell 92.8% year over year.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- 146.31M USD
- Year-over-year change
- —
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 146.31M | — |
| FY2024 | 2024-12-31 | 0 | — |
Other Financing Activities vs competitors
How HAVAU compares with its peers on the latest reported figures
- HAVAU's FY2025 other financing activities of $146.31M is the 2nd largest of the 7 companies compared; the peer median is $23.03M.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | FY2025 | $233.88M | — | — | — |
HAVAUHarvard Ave Acquisition Corporation Unit | FY2025 | $146.31M | — | — | — |
| LTM Mar 2026 | $65.61M | — | — | — | |
| LTM Dec 2025 | $45.56M | +69.5% | +4.9% | 153.4% | |
EURKEureka Acquisition Corp Class A Ordinary Share | LTM Mar 2026 | $27.55M | -147.0% | — | — |
BSAABEST SPAC I Acquisition Corp. | FY2025 | $876.77K | — | — | — |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $495.54K | +53.5% | — | — |
| Peer median (excluding HAVAU) | $23.03M | +53.5% | +4.9% | 153.4% | |
Competitors are the stored peer set for HAVAU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Net Income | (62) | 252.9K |
| Depreciation & Amortization | 0 | 0 |
| Deferred Income Tax | 0 | 0 |
| Stock-Based Compensation | 0 | 0 |
| Change in Working Capital | 21 | 0 |
| Accounts Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Accounts Payables | 0 | 0 |
| Other Working Capital | 21 | 0 |
| Other Non-Cash Items | 37 | (1.56M) |
| Operating Cash Flow | (4) | (1.31M) |
| Capital Expenditures | 4 | 0 |
| Acquisitions (Net) | 0 | 0 |
| Purchases of Investments | 0 | 0 |
| Sales of Investments | 0 | 0 |
| Other Investing Activities | 0 | (145M) |
| Investing Cash Flow | 0 | (145M) |
| Debt Repayment | 9 | 0 |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | 0 | 0 |
| Other Financing Activities | 0 | 146.31M |
| Financing Cash Flow | 8 | 146.31M |
| Effect of Forex Changes | 0 | 0 |
| Net Change in Cash | 4 | 0 |
| Free Cash Flow | 0 | (1.31M) |
Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAU
Intrinsic Alpha fair value
Locked
Current Price
$10.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.